Molybdenum Cofactor Deficiency
Autosomal recessive
A condition caused by changes in both copies of MOCS1, MOCS2 or GPHN, which are needed to make the molybdenum cofactor used by sulfite oxidase and other enzymes.
What a diagnosis changes
Fosdenopterin is an approved treatment for type A (MOCS1) and works best when started very early; carrier status is relevant to family planning.
Also known as
combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase; MOCOD
Includes 4 related subtypes ↓Hide subtypes ↑
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type A
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type B2
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
